Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) dropped 8.2% on Monday . The stock traded as low as $1.79 and last traded at $1.7999. 291,299 shares were traded during mid-day trading, an increase of 425% from the average session volume of 55,481 shares. The stock had previously closed at $1.96.
Alpha Tau Medical Stock Down 1.1%
The firm’s 50 day moving average price is $1.76 and its two-hundred day moving average price is $1.15.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Recommended Stories
- Five stocks we like better than Alpha Tau Medical
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
